Reengineering Aligned D-Orbital Energy Levels in FeMn Dual-Atom Nanozyme Inhibits Pyroptosis for Effective Alleviation of Inflammatory Diseases
- PMID: 41882928
- DOI: 10.1002/adma.72857
Reengineering Aligned D-Orbital Energy Levels in FeMn Dual-Atom Nanozyme Inhibits Pyroptosis for Effective Alleviation of Inflammatory Diseases
Abstract
Pyroptosis inhibition via Fe single-atom nanozymes is promising for inflammation therapy, but the common Fe-N4 configuration restricts oxygen intermediate desorption and lacks cooperative sites, thus limiting catalytic performance. To overcome this, we develop a FeMn dual-atom nanozyme supported on oxygen-nitrogen-doped bamboo-like carbon nanotubes (FeMnDA/BCNT). Through the precise alignment of Fe and Mn 3dz2 orbital energy levels by the electron-delocalized BCNT support in the FeMn-N/O active center, thereby lowering the dissociation energy barrier for *O2 or *H2O molecules, promoting O─O bond cleavage to bypass toxic ─OOH species, and thus accelerating the enzyme-like kinetics. Combined with a hierarchical porous bamboo-like structure of the BCNT that enhances high specific surface, atom exposure, and mass transfer, the FeMnDA/BCNT nanozymes exhibit potent superoxide dismutase (SOD), catalase (CAT), and glutathione peroxidase (GPx)-like activities. Further encapsulation with a macrophage membrane ([MM]FeMnDA/BCNT) confers excellent biocompatibility and active targeting ability toward inflammatory sites. The resulting [MM]FeMnDA/BCNT nanozymes target the inflammatory microenvironment, scavenges ROS, restores mitochondrial function, and suppresses NLRP3 inflammasome activation, thereby inhibiting pyroptosis. In vivo, [MM]FeMnDA/BCNT nanozymes show good biocompatibility and efficacy in treating osteoarthritis, acute liver injury, and acute kidney injury. This work provides a novel strategy for inflammatory disease therapy using a biomimetic dual-atom nanozyme.
Keywords: FeMn dual‐atom nanozymes; aligned d‐orbital; bamboo‐like carbon nanotubes; inflammatory; pyroptosis.
© 2026 Wiley‐VCH GmbH.
References
-
- Y. Liu, R. Pan, Y. Ouyang, et al., “Pyroptosis in Health and Disease: Mechanisms, Regulation and Clinical Perspective,” Signal Transduction and Targeted Therapy 9, no. 1 (2024): 245, https://doi.org/10.1038/s41392‐024‐01958‐2.
-
- B. Zhou, Z.‐H. Jiang, M.‐R. Dai, et al., “Full‐Length GSDME Mediates Pyroptosis Independent From Cleavage,” Nature Cell Biology 26, no. 9 (2024): 1545–1557, https://doi.org/10.1038/s41556‐024‐01463‐2.
-
- T. Ye, C. Wang, J. Yan, et al., “Lysosomal Destabilization: A Missing Link Between Pathological Calcification And Osteoarthritis,” Bioactive Materials 34 (2024): 37–50, https://doi.org/10.1016/j.bioactmat.2023.12.001.
-
- H. Li, Y. Wu, L. Xiang, et al., “A20 Attenuates Oxidized self‐DNA‐Mediated Inflammation in Acute Kidney Injury,” Signal Transduction and Targeted Therapy 10, no. 1 (2025): 154, https://doi.org/10.1038/s41392‐025‐02194‐y.
-
- Y. Wang, X. Liu, K. Li, et al., “Self‐Sulfhydrated, Nitro‐Fixed Albumin Nanoparticles as a Potent Therapeutic Agent for the Treatment of Acute Liver Injury,” ACS Nano 18, no. 31 (2024): 20772–20791, https://doi.org/10.1021/acsnano.4c07297.
Grants and funding
- GuikeLT2600640002/The Guangxi Science and Technology Innovation Platform Plan
- 2023GXNSFBA026020/Guangxi Natural Science Foundation
- 2021GXNSFAA075007/Guangxi Natural Science Foundation Program
- RC20180107/Science and Technology Innovation and Entrepreneurship Talent Cultivation Project of Nanning
- 82160429 52301303 52573316 82360426/National Natural Science Foundation of China
LinkOut - more resources
Full Text Sources
Miscellaneous
